SOLENO THERAPEUTICS INC - SLNO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | — | D | D | 10,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,666.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,666.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,124.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,666.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 635.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 1,333.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 17,536.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 10,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,666.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,666.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,124.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 2,666.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 635.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 823.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 1,333.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 10,491.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 9,063.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 10,491.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Business Officer | D | D | 4,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Business Officer | D | D | 64,286.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Business Officer | D | D | 17,786.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Commercial Officer | D | D | 32,800.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Commercial Officer | D | D | 29,200.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Commercial Officer | D | D | 91,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Commercial Officer | D | D | 64,507.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Development Officer | D | D | 4,700.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Development Officer | D | D | 72,321.0 | — | — | 0.0 | View | |
| May 18, 2026 | Chief Development Officer | D | D | 20,171.0 | — | — | 0.0 | View | |
| May 18, 2026 | Sr. VP of Clinical Development | D | D | 11,900.0 | — | — | 0.0 | View | |
| May 18, 2026 | Sr. VP of Clinical Development | D | D | 13,800.0 | — | — | 0.0 | View | |
| May 18, 2026 | Sr. VP of Clinical Development | D | D | 110,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | Sr. VP of Clinical Development | D | D | 39,823.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 1,333.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 11,900.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 13,800.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 16,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 49,262.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 11,667.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 2,445.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 18,842.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 2,333.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 22,702.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 10,046.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF FINANCIAL OFFICER | D | D | 67,660.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF FINANCIAL OFFICER | D | D | 39,200.0 | — | — | 0.0 | View | |
| May 18, 2026 | — | D | D | 16,991.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 11,900.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 13,800.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 16,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 55,392.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 11,667.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 2,445.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 18,800.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 666.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 4,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 4,999.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 1,741.0 | — | — | 0.0 | View | |
| May 18, 2026 | SEE REMARKS | D | D | 37,639.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 131,400.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 115,600.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 100,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 200,753.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 52,709.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 73,333.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 8,473.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 35,000.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 23,332.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 60.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 22,452.0 | — | — | 0.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | D | D | 583,656.0 | — | — | 0.0 | View |